Leuprorelin acetate Prescribing at HAXBY GROUP PRACTICE
Sex hormones and hormone antagonists in malignant disease | Malignant Disease and Immunosuppression
Items (12m)
352
Total Quantity
353
NHS Cost
£64.5K
vs National Avg
+659.6%
HAXBY GROUP PRACTICE prescribed 352 items of Leuprorelin acetate over the last 12 months at a cost of £64,519 to the NHS. This is 659.6% above the national average prescribing rate. Leuprorelin acetate is classified under Sex hormones and hormone antagonists in malignant disease in the BNF.
Monthly Prescribing Trend
Jun 2026
29
Jun 2026
19
Jun 2026
26
Jun 2026
31
Jun 2026
25
Jun 2026
32
Jun 2026
7
Jun 2026
33
Jun 2026
61
Jun 2026
26
Jun 2026
21
Jun 2026
42
Prescribing Details
| Total Items | 352 |
|---|---|
| Total Quantity | 353 |
| Total NHS Cost | £64,519 |
| Presentations | 5 different forms |
| vs National Average | +659.6% |
Leuprorelin acetate Prescribing Comparison
| This practice | 352 items |
|---|---|
| National average per practice | 46 items |
| Difference | +659.6% vs national average |
Explore More
Data sourced from NHSBSA English Prescribing Dataset, CQC, and GP Patient Survey. Prescribing data does not indicate quality of care. Higher prescribing rates may reflect patient demographics. Always consult your GP for medical advice.